| DIFHX | HBLVX | DIFHX / HBLVX | |
| Total Expense Ratio | 0.55 | 0.56 | 98% |
| Annual Report Gross Expense Ratio | 0.62 | 0.56 | 111% |
| Fund Existence | 14 years | 12 years | - |
| Gain YTD | 4.973 | 3.696 | 135% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.8B | 11.2B | 16% |
| Annual Yield % from dividends | 5.82 | 3.44 | 169% |
| Returns for 1 year | 11.53 | 6.31 | 183% |
| Returns for 3 years | 28.70 | 20.14 | 142% |
| Returns for 5 years | 17.38 | 8.94 | 194% |
| Returns for 10 years | 58.96 | 46.38 | 127% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PIIMX | 42.13 | -0.12 | -0.28% |
| Principal Glb Emerging Markets R6 | |||
| ECHSX | 12.39 | -0.11 | -0.88% |
| Eaton Vance Worldwide Health Sci C | |||
| RINCX | 23.15 | -0.25 | -1.07% |
| Victory RS Science and Technology C | |||
| BMCIX | 31.59 | -0.38 | -1.19% |
| BlackRock High Equity Income Instl | |||
| RLSIX | 14.88 | -0.20 | -1.33% |
| RiverPark Long/Short Opportunity Instl | |||